Skip to main content
. Author manuscript; available in PMC: 2015 Mar 10.
Published in final edited form as: Schizophr Res. 2013 Jan 3;143(0):231–238. doi: 10.1016/j.schres.2012.11.029

Table 1.

Comparison of the demographic characteristics for first-episode schizophrenia and healthy control

FESZ
(Mean±SD)
(n=17)
HC
(Mean±SD)
(n=17)
t df p
Age at scan(years) 21.5±4.8 23.1±3.5 −1.11 32 0.27
Gender(Male/Female) 13/4 12/5 1.00a
Education(years) 13.7±3.1 14.1±1.7 −0.50 23.7 0.62
Parental SES 2.3±1.5 1.7±0.7 1.25 20.3 0.23
Current estimated
Iintellectual ability
114.1±11.7 118.9±10.4 −1.1 25 0.27
Ethnicity (H/N/U)b 4/13/0 1/15/1
 Asian East
 Southwest
1
 Asian, Western 9
 Black or African
 American
1 4
 White 14 3
 Other 1 16
Medication duration
(months)c
4.56±3.10
Medication dose (mg) d 393.3 ±358.2
WCSTe categories
completed
3.2±1.7 5.4±1.4 −3.4 23 0.02

FESZ, first-episode schizophrenia; HC, healthy control; SES; socioeconomic status. Current iIntellectual ability was estimated with 2 subtests from the measured by WASI or WAIS-III IQ

a

Fisher’s exact test.

b

Ethnicity: H=Hispanic or Latino; N=Not Hispanic or Latino; U=Unknown

c

Antipsychotic medication duration of all patients

d

Antipsychotic medication dose of all patients equivalent to chloropromazine at the time of scan.

e

WCST: the Wisconsin Card Sorting Test